The exciting news about REGENXBIO (NASDAQ: RGNX) will be shared on Wednesday 6th November 2024. Investors and analysts are eagerly waiting to hear about the company's financial performance for the third quarter of 2024. This significant announcement will happen after market close.
the organization is expected to report an estimated per share $1.12 loss for the quarter, as predicted by financial analysts on Wall Street. Furthermore, the company is anticipated to disclose a total revenue of $23.59 million during this period.
The earnings report for the corresponding quarter in the previous year showcased a per-share loss of $1.41. This considerable sum was attributed to the company's total revenue, which reached an impressive $28.91 million during that specific quarter.
Wall Street analysts have unveiled their forecasts for the company's yearly performance, estimating a total revenue of $95.41 million. Additionally, they expect the company to reach loss of $4.65 per share for the fiscal year.
Additionally, The company will host a conference call with investors and analysts on 6th November 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
REGENXBIO (RGNX) closed Friday's regular trading session at $8.79, showing a 2.33 percent advance, with a volume of 439.70 thousand shares.
